Aktionärsstruktur der Eli Lilly and Company

255 News & Informationen zur Eli Lilly Aktie

  • JD.com Announces 2021 Second Quarter and Interim Results
    globenewswire.com

    JD.com Announces 2021 Second Quarter and Interim Results

    BEIJING, China, Aug. 23, 2021 (GLOBE NEWSWIRE) — JD.com, Inc. (NASDAQ: JD and HKEX: 9618), a leading supply chain-based technology and service provider,…

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    markets.businessinsider.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    SAN FRANCISCO, Aug. 20, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research comp…

  • Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026
    prnewswire.com

    Global Anti-Inflammatory Therapeutics Market to Reach $130.9 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Psoriatic Arthritis Markets, 2018-2020 & 2021-2030 - Focus On United States, Germany, Spain, Italy, France, United Kingdom, And Japan
    thestreet.com

    Psoriatic Arthritis Markets, 2018-2020 & 2021-2030 – Focus On United States, Germany, Spain, Italy, France, United Kingdom, And Japan

    DUBLIN, Aug. 20, 2021 /PRNewswire/ — The “Psoriatic Arthritis – Market Insight, Epidemiology and Market Forecast – 2030” report has been added to

  • Psoriatic Arthritis Markets, 2018-2020 & 2021-2030 - Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan
    prnewswire.com

    Psoriatic Arthritis Markets, 2018-2020 & 2021-2030 – Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan

    /PRNewswire/ — The

  • 4 Stocks Insiders Are Selling
    benzinga.com

    4 Stocks Insiders Are Selling

    When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this …

  • Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis - Forecast to 2026
    markets.businessinsider.com

    Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis – Forecast to 2026

    DUBLIN, Aug. 19, 2021 /PRNewswire/ — The 'Global Atopic Dermatitis Drugs Market (2021-2026) by Drug Class, Route of Administration, Geography, Co…

  • U.S. Degenerative Disc Disease Treatment Market to Surpass 3.958 Million patients by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    U.S. Degenerative Disc Disease Treatment Market to Surpass 3.958 Million patients by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, Aug. 19, 2021 (GLOBE NEWSWIRE) — U.S. Degenerative Disc Disease Treatment Market to Surpass 3.958 Million patients by 2028, Says Coherent…

  • The Top 3 Healthcare Dividend Stocks to Buy and Hold
    entrepreneur.com

    The Top 3 Healthcare Dividend Stocks to Buy and Hold

    What’s even better is that many of these stocks offer dividends, allowing for even more gains over the long term. That’s why we’ve put together the fo…

  • Eli Lilly and : US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction
    marketscreener.com

    Eli Lilly and : US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

    RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 18, 2021 /PRNewswire/ — Jardiance® 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of… | August 18, 2021

  • Global Myocardial Infarction Market to Surpass US$ 2,714.8 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global Myocardial Infarction Market to Surpass US$ 2,714.8 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, Aug. 18, 2021 (GLOBE NEWSWIRE) — Global Myocardial Infarction Market to Surpass US$ 2,714.8 Million by 2028, Says Coherent Market Insights…

  • EQRx Appoints Richard Buckley As Chief Corporate Affairs Officer
    thestreet.com

    EQRx Appoints Richard Buckley As Chief Corporate Affairs Officer

    EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today

  • Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence
    markets.businessinsider.com

    Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence

    NEW YORK, Aug. 18, 2021 /PRNewswire/ — From $7,276.9 million in 2020, the size of the global home-use insulin delivery devices market will increa…

  • Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence
    prnewswire.com

    Home-Use Insulin Delivery Devices Market to Hit $19,087.6 Million Revenue by 2030 says P&S Intelligence

    /PRNewswire/ — From $7,276.9 million in 2020, the size of the global home-use insulin delivery devices market will increase to $19,087.6 million in 2030, at a…

  • Global Active Pharmaceutical Ingredients/API Market To Reach $274.8 Billion By 2026
    thestreet.com

    Global Active Pharmaceutical Ingredients/API Market To Reach $274.8 Billion By 2026

    SAN FRANCISCO, Aug. 17, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026
    prnewswire.com

    Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • 2 Dow Stocks to Buy Hand Over Fist This Month
    entrepreneur.com

    2 Dow Stocks to Buy Hand Over Fist This Month

    The Dow Jones Industrial Average (DJIA) notched a fresh record close yesterday, despite fears surrounding the resurgence of COVID-19 cases and geopoli…

  • The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra...
    news.google.com

    The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-

  • Global Veterinary Pharmaceuticals Markets to 2030 with Merck & Co, Zoetis, Eli Lilly and Co, Bayer, and Boehringer Ingelheim Dominating
    prnewswire.com

    Global Veterinary Pharmaceuticals Markets to 2030 with Merck & Co, Zoetis, Eli Lilly and Co, Bayer, and Boehringer Ingelheim Dominating

    /PRNewswire/ — The “Veterinary Pharmaceuticals Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to…

  • Eli Lilly and : Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units
    marketscreener.com

    Eli Lilly and : Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units

    INDIANAPOLIS, Aug. 17, 2021 /PRNewswire/ — Eli Lilly and Company today announced executive leadership changes and the creation of neuroscience and immunology business units. These changes… | August 17, 2021

  • Questex Announces the 2021 Fierce Pharma Marketing Awards Finalists
    globenewswire.com

    Questex Announces the 2021 Fierce Pharma Marketing Awards Finalists

    Winners to be Revealed September 29 at Fierce Pharma Marketing Awards Dinner in Philadelphia, During the Digital Pharma East Conference…

  • FDA Approves Pump Use For Lilly's Insulin
    markets.businessinsider.com

    FDA Approves Pump Use For Lilly's Insulin

    (RTTNews) – Eli Lilly and Company (LLY) said FDA has approved an expanded label for the company's insulin Lyumjev to include administration via co…

  • Global $3.84 Billion Companion Animal Veterinary Vaccines Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
    prnewswire.com

    Global $3.84 Billion Companion Animal Veterinary Vaccines Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F

    /PRNewswire/ — The “Companion Animal Veterinary Vaccines Global Market Report 2021: COVID-19 Growth and Change to 2030” report has been added to…

  • From studying pets to rethinking wastewater, B.C. researchers tap $25m from province
    biv.com

    From studying pets to rethinking wastewater, B.C. researchers tap $25m from province

    Researchers at five of B.C.’s biggest post-secondary centres are tapping $25 million from Victoria to examine everything from the relationship between people and their pets to how best to treat wastewater.

  • Eli Lilly and Company - Great Business, Horrible Investment (NYSE:LLY)
    seekingalpha.com

    Eli Lilly and Company – Great Business, Horrible Investment (NYSE:LLY)

    Eli Lilly and Company reported great quarterly results and continued its great run over the last few years.

  • Rigel Pharmaceuticals : Provides Update on COVID-19 Program
    marketscreener.com

    Rigel Pharmaceuticals : Provides Update on COVID-19 Program

    SOUTH SAN FRANCISCO, Calif., Aug. 13, 2021 /PRNewswire/ — Rigel Pharmaceuticals, Inc. , today announced that the U.S. Food and Drug Administration has informed the Company that clinical data… | August 13, 2021

  • Rigel Pharmaceuticals Provides Update on COVID-19 Program
    prnewswire.com

    Rigel Pharmaceuticals Provides Update on COVID-19 Program

    /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that…

  • ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
    globenewswire.com

    ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights

    BURLINGAME, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology…

  • Got $2,000? Buy and Hold These 2 Market-Beating Stocks By StockNews
    investing.com

    Got $2,000? Buy and Hold These 2 Market-Beating Stocks By StockNews

    Got $2,000? Buy and Hold These 2 Market-Beating Stocks

  • This Sierra Ventures-Backed Decentralized Clinical Trial Startup Raised $220M To Accelerate Clinical Trials
    cbinsights.com

    This Sierra Ventures-Backed Decentralized Clinical Trial Startup Raised $220M To Accelerate Clinical Trials

    The funding helps Reify Health’s valuation hit the $2.2B mark. Here are the top-line bullets you need to know.

  • Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.
    markets.businessinsider.com

    Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.

    SAN FRANCISCO, Aug. 12, 2021 /PRNewswire/ — The global regenerative medicine market size is expected to reach USD 57.08 billion by 2027, growing …

  • $50m vaccine-manufacturing site set for Vancouver’s False Creek Flats
    biv.com

    $50m vaccine-manufacturing site set for Vancouver’s False Creek Flats

    Vancouver’s east side will serve as the site for a 75,000-sqaure-foot facility capable of manufacturing both vaccines and biotech therapeutics.

  • The Hunt For Quality - Eli Lilly And Company Stock (NYSE:LLY)
    seekingalpha.com

    The Hunt For Quality – Eli Lilly And Company Stock (NYSE:LLY)

    Eli Lilly is a great company with an impressive portfolio and a great pipeline. Here’s why I call LLY a hold.

  • 4 Top Healthcare Stocks on the Dow Jones Index
    entrepreneur.com

    4 Top Healthcare Stocks on the Dow Jones Index

    The Dow Jones Industrial Average closed at a record high last week, with stocks tied to economic recovery gaining significantly after a strong jobs re…

  • 3 Healthcare Stocks That Could Make Your Portfolio Shine
    entrepreneur.com

    3 Healthcare Stocks That Could Make Your Portfolio Shine

    We believe that the resurgence of COVID-19 cases, technological advancements, and an increasing focus on finding cures for various critical diseases s…

  • CORRECTING and REPLACING - GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients
    marketscreener.com

    CORRECTING and REPLACING – GoodRx and Boehringer Ingelheim Announce Joint Effort to Deliver Affordability Solutions to Patients

    SANTA MONICA, Calif., Aug. 09, 2021 — In a release issued earlier today by GoodRx, Inc. , please note the announcement has been revised to include information about Synjardy®, Synjardy… | August 9, 2021

  • Avidity Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights
    prnewswire.com

    Avidity Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights

    /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody…

  • 5 Stocks Insiders Are Selling
    benzinga.com

    5 Stocks Insiders Are Selling

    When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this …

  • Were Hedge Funds Right About AbbVie Inc (ABBV)?
    insidermonkey.com

    Were Hedge Funds Right About AbbVie Inc (ABBV)?

    The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database.

  • Were Hedge Funds Right About Merck & Co., Inc. (MRK)?
    insidermonkey.com

    Were Hedge Funds Right About Merck & Co., Inc. (MRK)?

    Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Eli Lilly Aktie

Das Unternehmen Eli Lilly and Company aus USA ist in den Bereichen Chemie & Pharma, Einzelhandel (Medikamente), Einzelhandel, Pharma tätig.

Das Unternehmen Eli Lilly and Company ist in mehr als 72 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Pharmaceutical ETF gewichtet Eli Lilly mit 5,66% im ETF.

Entdecke die 6 ETFs in denen Eli Lilly and Company am höchsten gewichtet ist Insgesamt in 72 ETFs enthalten

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Eli Lilly?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect